These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
200 related articles for article (PubMed ID: 17475913)
1. Reintroduction of C/EBPalpha in leukemic CD34+ stem/progenitor cells impairs self-renewal and partially restores myelopoiesis. Schepers H; Wierenga AT; van Gosliga D; Eggen BJ; Vellenga E; Schuringa JJ Blood; 2007 Aug; 110(4):1317-25. PubMed ID: 17475913 [TBL] [Abstract][Full Text] [Related]
2. Ex vivo assays to study self-renewal and long-term expansion of genetically modified primary human acute myeloid leukemia stem cells. Schuringa JJ; Schepers H Methods Mol Biol; 2009; 538():287-300. PubMed ID: 19277587 [TBL] [Abstract][Full Text] [Related]
3. STAT5-induced self-renewal and impaired myelopoiesis of human hematopoietic stem/progenitor cells involves down-modulation of C/EBPalpha. Wierenga AT; Schepers H; Moore MA; Vellenga E; Schuringa JJ Blood; 2006 Jun; 107(11):4326-33. PubMed ID: 16455947 [TBL] [Abstract][Full Text] [Related]
4. Establishing long-term cultures with self-renewing acute myeloid leukemia stem/progenitor cells. van Gosliga D; Schepers H; Rizo A; van der Kolk D; Vellenga E; Schuringa JJ Exp Hematol; 2007 Oct; 35(10):1538-49. PubMed ID: 17889721 [TBL] [Abstract][Full Text] [Related]
5. Constitutive activation of Flt3 and STAT5A enhances self-renewal and alters differentiation of hematopoietic stem cells. Moore MA; Dorn DC; Schuringa JJ; Chung KY; Morrone G Exp Hematol; 2007 Apr; 35(4 Suppl 1):105-16. PubMed ID: 17379095 [TBL] [Abstract][Full Text] [Related]
6. C/EBPα in normal and malignant myelopoiesis. Friedman AD Int J Hematol; 2015 Apr; 101(4):330-41. PubMed ID: 25753223 [TBL] [Abstract][Full Text] [Related]
7. A dominant-negative mutant of C/EBPalpha, associated with acute myeloid leukemias, inhibits differentiation of myeloid and erythroid progenitors of man but not mouse. Schwieger M; Löhler J; Fischer M; Herwig U; Tenen DG; Stocking C Blood; 2004 Apr; 103(7):2744-52. PubMed ID: 14656889 [TBL] [Abstract][Full Text] [Related]
8. C/EBPalpha and the pathophysiology of acute myeloid leukemia. Mueller BU; Pabst T Curr Opin Hematol; 2006 Jan; 13(1):7-14. PubMed ID: 16319681 [TBL] [Abstract][Full Text] [Related]
9. Ectopic expression of C/EBPalpha and ID1 is sufficient to restore defective neutrophil development in low-risk myelodysplasia. Geest CR; Buitenhuis M; Vellenga E; Coffer PJ Haematologica; 2009 Aug; 94(8):1075-84. PubMed ID: 19644139 [TBL] [Abstract][Full Text] [Related]
10. Repression of BMI1 in normal and leukemic human CD34(+) cells impairs self-renewal and induces apoptosis. Rizo A; Olthof S; Han L; Vellenga E; de Haan G; Schuringa JJ Blood; 2009 Aug; 114(8):1498-505. PubMed ID: 19556423 [TBL] [Abstract][Full Text] [Related]
11. ELMO1 is upregulated in AML CD34+ stem/progenitor cells, mediates chemotaxis and predicts poor prognosis in normal karyotype AML. Capala ME; Vellenga E; Schuringa JJ PLoS One; 2014; 9(10):e111568. PubMed ID: 25360637 [TBL] [Abstract][Full Text] [Related]
12. Elevated c-Jun expression in acute myeloid leukemias inhibits C/EBPalpha DNA binding via leucine zipper domain interaction. Rangatia J; Vangala RK; Singh SM; Peer Zada AA; Elsässer A; Kohlmann A; Haferlach T; Tenen DG; Hiddemann W; Behre G Oncogene; 2003 Jul; 22(30):4760-4. PubMed ID: 12879022 [TBL] [Abstract][Full Text] [Related]
13. A C-terminal mutant of CCAAT-enhancer-binding protein α (C/EBPα-Cm) downregulates Csf1r, a potent accelerator in the progression of acute myeloid leukemia with C/EBPα-Cm. Togami K; Kitaura J; Uchida T; Inoue D; Nishimura K; Kawabata KC; Nagase R; Horikawa S; Izawa K; Fukuyama T; Nakahara F; Oki T; Harada Y; Harada H; Aburatani H; Kitamura T Exp Hematol; 2015 Apr; 43(4):300-8.e1. PubMed ID: 25534203 [TBL] [Abstract][Full Text] [Related]
14. Acetylation of C/EBPα inhibits its granulopoietic function. Bararia D; Kwok HS; Welner RS; Numata A; Sárosi MB; Yang H; Wee S; Tschuri S; Ray D; Weigert O; Levantini E; Ebralidze AK; Gunaratne J; Tenen DG Nat Commun; 2016 Mar; 7():10968. PubMed ID: 27005833 [TBL] [Abstract][Full Text] [Related]
15. Growth of CD34+ acute myeloblastic leukemia colony-forming cells in response to recombinant hematopoietic growth factors. Carlo-Stella C; Mangoni L; Almici C; Frassoni F; Fiers W; Rizzoli V Leukemia; 1990 Aug; 4(8):561-6. PubMed ID: 1697011 [TBL] [Abstract][Full Text] [Related]
16. Two types of C/EBPα mutations play distinct but collaborative roles in leukemogenesis: lessons from clinical data and BMT models. Kato N; Kitaura J; Doki N; Komeno Y; Watanabe-Okochi N; Togami K; Nakahara F; Oki T; Enomoto Y; Fukuchi Y; Nakajima H; Harada Y; Harada H; Kitamura T Blood; 2011 Jan; 117(1):221-33. PubMed ID: 20884804 [TBL] [Abstract][Full Text] [Related]
17. Granulopoiesis requires increased C/EBPα compared to monopoiesis, correlated with elevated Cebpa in immature G-CSF receptor versus M-CSF receptor expressing cells. Ma O; Hong S; Guo H; Ghiaur G; Friedman AD PLoS One; 2014; 9(4):e95784. PubMed ID: 24752325 [TBL] [Abstract][Full Text] [Related]